About this raise
Canine Biologics, with a valuation of $6.1 million, is raising funds on NetCapital. The company makes nutrition products to support dogs battling cancer. It uses the highest-quality ingredients, top-tier expertise, and inspired thinking to make pet nutrition products with specialized supplements, vitamins, and minerals. Canine Biologics is a unique company with an expanded product roadmap, including a liquid diet for dogs and formulated treats. Jeff Sutherland founded Canine Biologics in 2019. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $477,540. The campaign proceeds will be used for new product development, inventory purchases, selling and marketing costs, administrative costs, and compensation for managers.
Investment Overview
Invested : $39,141
Deal Terms
Total Commitments
- Platform
- Netcapital
- Start Date
- 09/09/2021
- Close Date
- 03/08/2022
$10,000
$477,540
$100
Equity - Common
Early Stage
RegCF
$0.81
$6,123,284
Company & Team
Company
- Year Founded
- 2021
- Industry
- Pet Health, Food, and Services
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Low
- Capital Intensity
- High
Financials
-
Revenue
- $5,823
- Monthly Burn
- $29,460
-
Runway
- 3.4 months
- Gross Margin
- 3%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.